[{"_id":"551f89c031cae9239deb20bb","会社名":"(株)ドクターシーラボ【4924】","証券コード":"4924","決算期":"2014年7月期","会計方式":"日本方式","決算発表日":"2014年9月10日","決算月数":"12か月","売上高":"35,916百万円","営業利益":"7,510百万円","経常利益":"7,569百万円","当期利益":"4,588百万円","EPS（一株当たり利益）":"184.09円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"912.33円","総資産":"27,691百万円","自己資本":"22,741百万円","資本金":"1,209百万円","有利子負債":"---","自己資本比率":"82.1%","ROA（総資産利益率）":"17.80%","ROE（自己資本利益率）":"21.40%","総資産経常利益率":"29.37%","__v":0,"日付":"2015-04-04T06:50:40.880Z"},{"_id":"551f89c031cae9239deb20bc","会社名":"(株)ドクターシーラボ【4924】","証券コード":"4924","決算期":"2013年7月期","会計方式":"日本方式","決算発表日":"2013年9月10日","決算月数":"12か月","売上高":"33,990百万円","営業利益":"7,585百万円","経常利益":"7,810百万円","当期利益":"4,789百万円","EPS（一株当たり利益）":"19,219.93円","調整一株当たり利益":"19,217.75円","BPS（一株当たり純資産）":"80,779.17円","総資産":"23,851百万円","自己資本":"20,136百万円","資本金":"1,209百万円","有利子負債":"---","自己資本比率":"84.4%","ROA（総資産利益率）":"20.70%","ROE（自己資本利益率）":"25.65%","総資産経常利益率":"33.76%","__v":0,"日付":"2015-04-04T06:50:40.880Z"},{"_id":"551f89c031cae9239deb20bd","会社名":"(株)ドクターシーラボ【4924】","証券コード":"4924","決算期":"2012年7月期","会計方式":"日本方式","決算発表日":"2012年9月7日","決算月数":"12か月","売上高":"39,082百万円","営業利益":"8,963百万円","経常利益":"8,998百万円","当期利益":"5,036百万円","EPS（一株当たり利益）":"20,079.50円","調整一株当たり利益":"20,071.11円","BPS（一株当たり純資産）":"69,045.21円","総資産":"22,420百万円","自己資本":"17,205百万円","資本金":"1,201百万円","有利子負債":"---","自己資本比率":"76.7%","ROA（総資産利益率）":"23.64%","ROE（自己資本利益率）":"31.91%","総資産経常利益率":"42.23%","__v":0,"日付":"2015-04-04T06:50:40.881Z"}]